Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #671

    Vi har arbejdet sammen før. Nu fik vi muligheden igen.

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #672

      God morgen. 🙂

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bibob
        wrote on sidst redigeret af
        #673

        God morgen. 🙂

        1 Reply Last reply
        0
        • P Offline
          P Offline
          polle1
          wrote on sidst redigeret af
          #674

          God morgen og god dag 🙂

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #675

            NEJM : Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation https://www.nejm.org/doi/full/10.1056/NEJMoa1807438

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #676

              "Within 1 week after the initiation of treatment with daratumumab, he no longer required transfusions." ………..wtf

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #677

                New trial: Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction (IDA53) https://clinicaltrials.gov/ct2/show/NCT03734198

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  Parasitism
                  wrote on sidst redigeret af
                  #678

                  God morgen 🙂

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #679

                    and if you are on twitter , have a look at Natalie Callander‏ @nsc_natalie where she talks about a new trial in preparation for Smoldering , Dara + Len/dex, which she hopes to start Feb19

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #680

                      https://twitter.com/mtmdphd/status/1060287065903034368

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #681

                        God morgen indeed 😉

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #682

                          The SC combo trial adds an extra arm, (D-Kd)
                          https://clinicaltrials.gov/ct2/history/NCT03412565?A=12&B=13&C=merged

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #683

                            Thanks El. Og lidt apropos: WM cell lines treated with the ibrutinib + Dara combination, showed significantly more cell death through ADCC, CDC, ADCP and apoptosis relative to single‐agent Dara or ibrutinib. In summary, we are the first to report the in vitro and in vivo anti‐WM activity of Dara. Furthermore, we show a close connection between BCR and CD38 signalling, which can be co‐targeted with ibrutinib + Dara to induce marked WM cell death.(British Journal of Haematology 183(2) · August18

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              polle1
                              wrote on sidst redigeret af
                              #684

                              "Pop" 🙂

                              1 Reply Last reply
                              0
                              • O Offline
                                O Offline
                                OHW
                                wrote on sidst redigeret af
                                #685

                                Fin kursudvikling 🙂

                                1 Reply Last reply
                                0
                                • Legolas23L Offline
                                  Legolas23L Offline
                                  Legolas23
                                  wrote on sidst redigeret af
                                  #686

                                  THX for link

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #687

                                    Ser ud til shorts er øget med 0.4% i.f.t September som var 3.27% 30 sept. mod nu 3.65% 31 okt.

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Parasitism
                                      wrote on sidst redigeret af
                                      #688

                                      Det passer vel også meget godt - var det ikke ca. 1 nov. at AB begyndte at ligge som største nettokøber mange af dagene?

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #689

                                        Despite the addition of a new arm, the sc combo trial is shortened down with almost a year. And at the same time the observation time frames are extended with a year. Any ideas how this fits together?

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #690

                                          I can only think that recruitment is going much faster as expected? And it would almost imply this 4th arm is already recruiting?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger